United States
Securities and Exchange Commission
Form 12b-25
SEC File No.: 333-128226
CUSIP No.: 45822W100
NOTIFICATION OF LATE FILING
(Check One): |X| Form 10-K and Form 10-KSB |_| Form 20-F |_| Form 11-K
|_| Form 10-Q and Form 10-QSB |_| Form N-SAR
For Period Ended: June 30, 2007
|_| Transition report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-K
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended: _______________________________________________
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates.
PART I: - REGISTRANT INFORMATION
Intellect Neurosciences, Inc.
---------------------------------------------------------------------
Full Name of Registrant
---------------------------------------------------------------------
Former Name if Applicable
7 West 18th Street
New York, NY 10011
---------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
City, State and Zip Code
PART II - RULES 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)
| (a) The reasons described in reasonable detail in Part III of this
| form could not be eliminated without unreasonable effort or
| expense;
|
|X| | (b) The subject annual report, semi-annual report, transition
| report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or
| portion thereof, will be filed on or before the fifteenth
| calendar day following the prescribed due date; or the subject
| quarterly report or transition report on Form 10-Q, or portion
| thereof, will be filed on or before the 5th calendar day after
| the prescribed due date; and
|
| (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 10-Q, N-SAR,
or the transition report or portion thereof, could not be filed within the
prescribed time period.
Intellect Neurosciences, Inc. (the "Company") is currently obtaining additional
information to accurately complete its financial statements for the year ended
June 30, 2007. As a result, the Company requires additional time to complete the
Form 10-KSB regarding the year ended June 30, 2007 and cannot timely file that
form without unreasonable effort or expense.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Elliot Maza 212-448-9300
--------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such reports(s) been filed? If answer
is no, identity report(s).
|X| Yes |_| No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or portion
thereof?
|X| Yes |_| No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
The Company has ceased operations as a shell company since the corresponding
period for the last fiscal year. This change occurred during the year ended June
30, 2007. The Company's Report on Form 10-KSB for the year ended June 30, 2007
will reflect results of operations of the Company's operating company
subsidiary, Intellect USA, Inc.
INTELLECT NEUROSCIENCES, INC.
------------------------------------------
Name of Registrant as Specified in Charter
The registrant has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
INTELLECT NEUROSCIENCES, INC.
Date: October 1, 2007 By: /s/ Elliot Maza
-------------------------------------
Elliot Maza
President and Chief Financial Officer